We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDS icon
26
Telephone and Data Systems
TDS
$3.88B
$6.84M 1.05%
192,178
EVRI
27
DELISTED
Everi Holdings
EVRI
$6.42M 0.99%
450,764
+5,000
+1% +$69.9K
GSRT
28
DELISTED
GSR III Acquisition Corp
GSRT
$6.27M 0.96%
+581,000
New +$6.06M
AZEK
29
DELISTED
The AZEK Co
AZEK
$6.12M 0.94%
112,604
+22,149
+24% +$1.11M
SRDX
30
DELISTED
Surmodics
SRDX
$6.05M 0.93%
203,587
+8,200
+4% +$236K
SOUL.U
31
Soulpower Acquisition Corp Units
SOUL.U
$273M
$5.81M 0.89%
+572,100
New +$5.75M
BATRK icon
32
Atlanta Braves Holdings Series B
BATRK
$3.21B
$5.72M 0.88%
122,243
-34,372
-22% -$1.41M
RDUS
33
DELISTED
Radius Recycling
RDUS
$5.58M 0.86%
187,900
+97,800
+109% +$2.87M
AGS
34
DELISTED
PlayAGS
AGS
$5.54M 0.85%
443,364
+24,000
+6% +$293K
AD
35
Array Digital Infrastructure
AD
$3.03B
$5.48M 0.84%
85,600
+9,650
+13% +$614K
CCRN
36
DELISTED
Cross Country Healthcare
CCRN
$5.42M 0.83%
415,150
-20,850
-5% -$287K
PARAA
37
DELISTED
Paramount Global Class A
PARAA
$5.29M 0.81%
230,361
+84,553
+58% +$1.91M
NLOP
38
Net Lease Office Properties
NLOP
$170M
$4.93M 0.76%
151,353
+14,050
+10% +$430K
LBRDK icon
39
Liberty Broadband Class C
LBRDK
$5.18B
$4.9M 0.75%
49,794
+4,886
+11% +$438K
AMZN icon
40
Amazon
AMZN
$3T
$4.83M 0.74%
22,000
IPG
41
DELISTED
Interpublic Group of Companies
IPG
$4.78M 0.73%
195,096
+128,397
+193% +$3.12M
TGNA
42
DELISTED
TEGNA Inc
TGNA
$4.52M 0.69%
269,711
-39,525
-13% -$657K
ESGR
43
DELISTED
Enstar Group
ESGR
$4.36M 0.67%
12,950
+600
+5% +$201K
GB
44
DELISTED
Global Blue Group Holding
GB
$4.28M 0.66%
572,800
+18,250
+3% +$135K
COOP
45
DELISTED
Mr. Cooper
COOP
$4.18M 0.64%
+27,996
New +$3.59M
VERV
46
DELISTED
Verve Therapeutics
VERV
$3.4M 0.52%
+302,400
New +$1.72M
SGRY icon
47
Surgery Partners
SGRY
$2.09B
$3.25M 0.5%
146,250
+68,400
+88% +$1.52M
CCIX
48
DELISTED
Churchill Capital Corp IX
CCIX
$3.25M 0.5%
308,750
-64,150
-17% -$698K
INFA
49
DELISTED
Informatica
INFA
$3.1M 0.48%
+127,200
New +$2.62M
ACI icon
50
Albertsons Companies
ACI
$5.89B
$3.06M 0.47%
142,295
-185,310
-57% -$4.03M

Similar funds

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.